Abdominal magnetic resonance imaging for rare genetic conditions associated with risk of renal tumours – new items for 1 July 2024

This page provides information about two new abdominal magnetic resonance imaging (MRI) services which will be listed on the Medicare Benefits Schedule from 1 July 2024 for rare genetic conditions associated with risk of renal tumours.

Page last updated: 21 June 2024

From 1 July 2024, items 63539 and 63540 will be listed on the Medicare Benefits Schedule to allow for annual surveillance to detect newly developed renal tumours, and ongoing assessment of changes over time to existing renal tumours, for patients with certain rare genetic conditions.

Further information can be found in the factsheet below:

PDF Version - New MRI abdominal items 63539 and 63540 (PDF 158 KB)
Word Version - New MRI abdominal items 63539 and 63540 (Word 123 KB)

In this section